Impact of left atrial posterior wall isolation using pulsed-field ablation in patients undergoing repeat catheter ablation for atrial fibrillation

Read full text
Authors: Patrick Badertscher, Corinne Isenegger, Thomas Küffer, Fabian Jordan, Valon Spahiu, Jonas Brugger, Hildegard Tanner, Philipp Krisai, Helge Servatius, Gregor Thalmann, Nicolas Schaerli, Nikola Kozhuharov
+10 more Claudia Herrera, Boldizsar Kovacs, Gian Voellmin, Felix Mahfoud, Sven Knecht, David Spreen, Christian Sticherling, Tobias Reichlin, Michael Kühne, Lauren Roten
Cited by: 1
References: 19

Abstract

BACKGROUND: Durable pulmonary vein isolation (PVI) is the primary objective of catheter ablation of atrial fibrillation (AF). In repeat procedures, posterior wall isolation (PWI) is the primary adjunctive target, particularly with pulsed-field ablation (PFA), although evidence supporting its clinical benefit remains limited. OBJECTIVE: This study aimed to compare procedural characteristics, safety, and efficacy of 2 ablation strategies in repeat AF ablation: redo PVI alone (PVI group) vs redo PVI with adjunctive PWI (PVI+ group). METHODS: Consecutive patients undergoing redo PVI at 2 centers, with 1-2 reconnected pulmonary veins identified on preablation mapping, were enrolled. PFA or radiofrequency ablation was used in the PVI group, whereas only PFA was used in the PVI+ group. Propensity score matching (1:1 ratio) was performed. RESULTS: A total of 122 patients were included in each group (median age 67 years; 30% female). Median left atrial diameter was 41 mm [37-46], and 46% had persistent AF. Procedure duration, left atrial dwell time, and fluoroscopy time were significantly shorter in the PVI group (all P < .001). Procedural success was 100% in both groups. 1 major complication occurred in each group (0.8%). At a median follow-up of 370 days, arrhythmia-free survival was 69% in the PVI group and 72% in the PVI+ group (P = .517). CONCLUSION: Redo PVI with or without adjunctive PWI is safe and effective, with comparable arrhythmia-free survival. Adjunctive PWI prolongs procedural duration without improving outcomes. Randomized trials are required to clarify its role.

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments Cardiac pacing and defibrillation studies

Publication details

Journal / source
Heart Rhythm
Publisher
Elsevier BV
Volume
23
Issue
4
Pages
829–835
Publication date
8 January 2026
Language
EN